Paige is Transforming Cancer Diagnostics

At Paige, we believe that better technology is the answer to better patient care. Our mission is to develop and deliver a new generation of diagnostic and biomarker AI applications, empowering pathologists and transforming oncology.

Redefining What Digital Pathology Can

Paige is the leader in delivering a web-based SaaS platform and AI applications that are thoughtfully designed to support pathologists in their diagnosis and transform the way oncologists treat patients. Rigorously tested and designed to work in a clinical setting, Paige provides unparalleled technology that empowers pathologists through every step in the diagnostic process, enhancing efficiency and confidence from scanned slide to case sign out.

The Paige Platform

With Paige’s flexible platform at the nexus of the digital pathology ecosystem, labs and pathologists can connect their existing and future digital pathology applications into a single environment managed by Paige. The Platform’s flexibility is powered by a set of APIs that allow for unlimited vendor-neutral integrations and enable custom workflows to be built on top of Paige’s already robust native capabilities. In addition to integrating within the workflow, the solution enables seamless access to both Paige’s AI solutions and third-party AI applications. This helps to support labs in taking an iterative approach to digital pathology adoption, reducing upfront investment, avoiding vendor lock-in and making the digital transition a frictionless experience for the entire pathology department. The Paige Platform was developed for superior user experience and functionality, placing everything a digital pathologist may need at their fingertips, including diverse WSI scanner and LIS integration capabilities, a CE-IVD & UKCA marked and FDA-cleared whole slide image viewer**, a digital case manager to help prioritize and streamline case review and immediate access to Paige and third-party AI applications. The Paige system is supported by sophisticated, economical data management and cloud-storage options and was developed against the most secure standards in the industry, achieving ISO 27001 certification. Paige is also HIPAA and GDPR compliant.

Paige's Diagnostic AI Applications

Paige’s cutting-edge AI was built upon one of the largest data sets used to develop AI software in pathology, with millions of slides from over 1,000 global institutions. As a result, our AI products generalize across labs, regardless of any pre-analytical variations or staining techniques, without the need for additional tuning. Our ground-breaking approach enabled us to build the first-ever FDA-approved AI for pathology, Paige Prostate Detect*.

Paige Prostate Suite

The Paige Prostate Suite is comprised of Paige Prostate Detect, Paige Prostate Grade & Quantify, Paige Prostate Perineural Invasion, and Paige Prostate Biomarker Panel. The AI applications available in the Paige Prostate Suite assist pathologist in identifying suspicious regions of interest for their review, which helps to increase read efficiency and confidence in their diagnoses.

Paige Breast Suite

The Paige Breast Suite is a comprehensive set of diagnostic AI applications designed to enhance pathologists’ efficiency and confidence in diagnosing breast cancers. Comprised of tools for detecting and classifying breast cancers, assessing mitotic count, identifying breast lymph node metastases, and detecting biomarkers associated with breast cancer, Paige Breast Suite puts the power of AI in the hands of pathologists to transform breast cancer diagnostic workflows.

Learn more about Paige at https://paige.ai/

---

*In the United States, Paige Prostate Detect (DEN200080) is approved for clinical use with Philips Ultrafast Scanner.
***In the United States, European Union & United Kingdom, FullFocus® (K201005) is cleared for clinical use with various scanner brands and models, including Philips Ultrafast, Leica AT2, Hamamatsu S60 and S360, and 3DHistech P1000 scanners.

Paige

by PAIGE.AI, INC.